TAF6δ controls apoptosis and gene expression in the absence of p53

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Wilhelm, Emmanuelle ^a   Pellay, François Xavier ^b   Benecke, Arndt ^b   Bell, Brendan ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PROTEIN P53; TATA BINDING PROTEIN ASSOCIATED FACTOR; TATA BINDING PROTEIN ASSOCIATED FACTOR 6 DELTA; OLIGONUCLEOTIDE; TAF6 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CELL DEATH; CELL STRAIN HCT116; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; LARYNX CARCINOMA; LUNG CANCER; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UTERINE CERVIX CANCER; BIOLOGICAL MODEL; CHEMISTRY; DNA MICROARRAY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; METABOLISM; METHODOLOGY;

METAZOA;

APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; SIGNAL TRANSDUCTION; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 50249110690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002721     Document Type: Article

References (66)

1. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776.
2. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
3. Fesus L (1999) Inducible gene expression in apoptosis [In Process Citation]. Cell Death Differ 6: 1144-1145.
4. Kumar S, Cakouros D (2004) Transcriptional control of the core cell-death machinery. Trends Biochem Sci 29: 193-199.
5. Schwerk C, Schulze-Osthoff K (2005) Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell 19: 1-13.
6. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283.
7. Liu G, Chen X (2002) The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 21: 7195-7204.
8. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, et al. (2001) Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 7: 1111-1117.
9. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Moll Cell 7: 673-682.
10. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
11. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
12. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, et al. (2000) p53AIPI, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862.
13. Bell B, Tora L (1999) Regulation of gene expression by multiple forms of TFIID and other novel TAFII-containing complexes. Exp Cell Res 246: 11-19.
14. Green MR (2000) TBP-associated factors (TAFIIs): multiple, selective transcriptional mediators in common complexes [In Process Citation]. Trends Biochem Sci 25: 59-63.
15. Muller F, Demeny MA, Tora L (2007) New problems in RNA polymerase II transcription initiation: matching the diversity of core promoters with a variety of promoter recognition factors. J Biol Chem 282: 14685-14689.
16. Albright S, Tjian R (2000) TAFs revisited: more data reveal new twists and confirm old ideas. Gene 242: 1-13.
17. Gangloff YG, Romier C, Thuault S, Werten S, Davidson I (2001) The histone fold is a key structural motif of transcription factor TFIID. Trends Biochem Sci 26: 250-257.
18. Yie X, Kokubo T, Cohen SL, Mirza UA, Hoffmann A, et al. (1996) Structural similarity between TAFs and the heterotetrameric core of the histone octamer [see comments]. Nature 380: 316-322.
19. Werten S, Mitschler A, Romier C, Gangloff YG, Thuault S, et al. (2002) Crystal structure of a subcomplex of human transcription factor TFIID formed by TATA binding protein-associated factors hTAF4 (hTAF(II)135) and hTAF12 (hTAF(II)20). J Biol Chem 277: 45502-45509.
20. Birck C, Poch O, Romier C, Ruff M, Mengus G, et al. (1998) Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family. Cell 94: 239-249.
21. Gangloff YG, Sanders SL, Romier C, Kirschner D, Weil PA, et al. (2001) Histone folds mediate selective heterodimerization of yeast TAF(II)25 with TFIID components yTAF(II)47 and yTAF(II)65 and with SAGA component ySPT7. Moll Cell Biol 21: 1841-1853.
22. Gangloff YG, Pointud JC, Thuault S, Carre L, Romier C, et al. (2001) The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD ringer. Moll Cell Biol 21: 5109-5121.
23. Wright KJ, Marr MT 2nd, Tjian R (2006) TAF4 nucleates a core subcomplex of TFIID and mediates activated transcription from a TATA-less promoter. Proc Natl Acad Sci U S A 103: 12347-12352.
24. Michel B, Komarnitsky P, Buratowski S (1998) Histone-like TAFs are essential for transcription in vivo. Mol Cell 2: 663-673.
25. Shen WC, Bhaumik SR, Causton HC, Simon I, Zhu X, et al. (2003) Systematic analysis of essential yeast TAFs in genome-wide transcription and preinitiation complex assembly. Embo J 22: 3395-3402.
26. Poon D, Bai Y, Campbell AM, Bjorklund S, Kim YJ, et al. (1995) Identification and characterization of a TFIID-like multiprotein complex from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 92: 8224-8228.
27. Lago C, Clerici E, Dreni L, Horlow C, Caporali E, et al. (2005) The Arabidopsis TFIID factor AtTAF6 controls pollen tube growth. Dev Biol 285: 91-100.
28. Aoyagi N, Wassarman DA (2001) Developmental and transcriptional consequences of mutations in Drosophila TAF(II)60. Mol Cell Biol 21: 6808-6819.
29. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, et al. (2004) Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A 101: 12792-12797.
30. Purrello M, Di Pietro C, Viola A, Rapisarda A, Stevens S, et al. (1998) Genomics and transcription analysis of human TFIID. Oncogene 16: 1633-1638.
31. Weinzierl RO, Ruppert S, Dynlacht BD, Tanese N, Tjian R (1993) Cloning and expression of Drosophila TAFII60 and human TAFII70 reveal conserved interactions with other subunits of TFIID. Embo J 12: 5303-5309.
32. Burke TW, Kadonaga JT (1997) The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 11: 3020-3031.
33. Shao H, Revach M, Moshonov S, Tzuman Y, Gazit K, et al. (2005) Core promoter binding by histone-like TAF complexes. Mol Cell Biol 25: 206-219.
34. Thut CJ, Chen JL, Klemm R, Tjian R (1995) p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267: 100-104.
35. Lu H, Levine AJ (1995) Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc Natl Acad Sci U S A 92: 5154-5158.
36. Farmer G, Colgan J, Nakatani Y, Manley JL, Prives C (1996) Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo. Mol Cell Biol 16: 4295-4304.
37. Jimenez GS, Nister M, Stommel JM, Beeche M, Barcarse EA, et al. (2000) A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat Genet 26: 37-43.
38. Johnson TM, Hammond EM, Giaccia A, Attardi LD (2005) The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality. Nat Genet 37: 145-152.
39. Bell B, Scheer E, Tora L (2001) Identification of hTAF(II)80 delta links apoptotic signaling pathways to transcription factor TFIID function. Mol Cell 8: 591-600.
40. Mercatante DR, Bortner CD, Cidlowski JA, Kole R (2001) Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. J Biol Chem 276: 16411-16417.
41. Brou C, Wu J, Ali S, Scheer E, Lang C, et al. (1993) Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL- VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Res 21: 5-12.
42. Dubrovskaya V, Lavigne AC, Davidson I, Acker J, Staub A, et al. (1996) Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex. Embo J 15: 3702-3712.
43. Noth S, Brysbaert G, Benecke A (2006) Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls. Genomics Proteomics Bioinformatics 4: 90-109.
44. Noth S, Benecke A (2005) Avoiding inconsistencies over time and tracking difficulties in Applied Biosystems AB1700/Panther probe-to-gene annotations. BMC Bioinformatics 6: 307.
45. Wang W, Nahta R, Huper G, Marks JR (2004) TAFII70 isoform-specific growth suppression correlates with its ability to complex with the GADD45a protein. Mol Cancer Res 2: 442-452.
46. Taylor JK, Zhang QQ, Wyatt JR, Dean NM (1999) Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense of oligonucleotides [see comments]. Nat Biotechnol 17: 1097-1100.
47. Mercatante DR, Mohler JL, Kole R (2002) Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. J Biol Chem 277: 49374-49382.
48. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, et al. (1999) Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis [In Process Citation]. J Pathol 187: 567-572.
49. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ (1987) Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A 84: 7716-7719.
50. May E, Jenkins JR, May P (1991) Endogenous HeLa p53 proteins are easily detected in HeLa cells transfected with mouse deletion mutant p53 gene-Oncogene 6: 1363-1365.
51. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
52. Noth S, Brysbaert G, Pellay FX, Benecke A (2006) High-sensitivity transcriptome data structure and implications for analysis and biologic interpretation. Genomics Proteomics Bioinformatics 4: 212-229.
53. Wang Y, Barbacioru C, Hyland F, Xiao W, Hunkapiller KL, et al. (2006) Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 7: 59.
54. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, et al. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15: 3032-3040.
55. Kunz C, Pebler S, Otte J, von der Ahe D (1995) Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 23: 3710-3717.
56. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
57. Muller F, Tora L (2004) The multicoloured world of promoter recognition complexes. Embo J 23: 2-8.
58. Gegonne A, Weissman JD, Zhou M, Brady JN, Singer DS (2006) TAF7: a possible transcription initiation check-point regulator. Proc Natl Acad Sci U S A 103: 602-607.
59. Deato MD, Tjian R (2007) Switching of the core transcription machinery during myogenesis. Genes Dev.
60. Mengus G, Fadloun A, Kobi D, Thibault C, Perletti L, et al. (2005) TAF4 inactivation in embryonic Fibroblasts activates TGF beta signalling and autocrine growth. Embo J 24: 2753-2767.
61. Frontini M, Soutoglou E, Argentini M, Bole-Feysot C, Jost B, et al. (2005) TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9. Mol Cell Biol 25: 4638-4649.
62. Katzenberger RJ, Marengo MS, Wassarman DA (2006) ATM and ATR pathways signal alternative splicing of Drosophila TAF1 pre-mRNA in response to DNA damage. Mol Cell Biol 26: 9256-9267.
63. Metcalf CE, Wassarman DA (2006) DNA binding properties of TAF1 isoforms with two AT-hooks. J Biol Chem 281: 30015-30023.
64. Robles LM, Warnpole JS, Christians MJ, Larsen PB (2007) Arabidopsis enhanced ethylene response 4 encodes an EIN3-interacting TFIID transcription factor required for proper ethylene response, including ERF1 induction. J Exp Bot.
65. Martins CP, Brown-Swigart L, Evan GI (2006) Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 127: 1323-1334.
66. Dressman HK, Hans C, Bild A, Olson JA, Rosen E, et al. (2006) Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 12: 819-826.